The U.S. baby infant formula market was valued at $3,889.0 million in 2020, and is projected to reach $6,784.7 million by 2030, registering a CAGR of 8.6% from 2021 to 2030.
Infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Enspire infant formula and toddler milk and Similac infant formula and toddler milk are infant formulas available for healthy, full-term infants who are not breastfed or partially breastfed.
The rise in the participation of women in the labor force in the U.S. acts as a key driving force of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population increased from 57.1% in 2018 to 57.5% in 2020. Infant formula acts as an appealing alternative to working mothers for their babies as per the need and convenience. Rapid urbanization and the growth of the middle-class population have led to changes in lifestyle.
The middle-class population is more affluent and can afford to spend more on their children, thus driving market growth. In addition, consumer perception of the high nutritional content in the infant formula supplements the market growth. Furthermore, an increase in health consciousness among consumers boosts the demand for infant formula having a high content of protein, minerals, and vitamins. However, concerns related to food safety and the decline in the birth rate are anticipated to hamper the market growth. On the contrary, a shift in preference for organic infant formulas is expected to offer new avenues for manufacturers.
The U.S. baby infant formula market is segmented on the basis of product type, ingredient, distribution channel, and source. Depending on product type, the market is segregated into infant milk, follow-on milk, specialty baby milk, and growing-up milk. On the basis of ingredient, it is fragmented into carbohydrates, fat, protein, minerals, vitamins, and others. By distribution channel, it is categorized into hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others. By source, it is classified into regular, organic, milk with HMO, goat milk, plant-based formula, and others.
The major players analyzed for the U.S. Baby Infant Formula Market are Abott Laboratories, Alra Foods Amba, Aussie Bub, Bobbie, Campbell Soups Company, Dana Dairy Group Ltd., Danone SA, D-Signstore, Else Nutrition Holdings Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC, Nestle S.A, Reckitt Benckiser Group Plc, and The Hain Celestial Group, Inc.
Infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Enspire infant formula and toddler milk and Similac infant formula and toddler milk are infant formulas available for healthy, full-term infants who are not breastfed or partially breastfed.
The rise in the participation of women in the labor force in the U.S. acts as a key driving force of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population increased from 57.1% in 2018 to 57.5% in 2020. Infant formula acts as an appealing alternative to working mothers for their babies as per the need and convenience. Rapid urbanization and the growth of the middle-class population have led to changes in lifestyle.
The middle-class population is more affluent and can afford to spend more on their children, thus driving market growth. In addition, consumer perception of the high nutritional content in the infant formula supplements the market growth. Furthermore, an increase in health consciousness among consumers boosts the demand for infant formula having a high content of protein, minerals, and vitamins. However, concerns related to food safety and the decline in the birth rate are anticipated to hamper the market growth. On the contrary, a shift in preference for organic infant formulas is expected to offer new avenues for manufacturers.
The U.S. baby infant formula market is segmented on the basis of product type, ingredient, distribution channel, and source. Depending on product type, the market is segregated into infant milk, follow-on milk, specialty baby milk, and growing-up milk. On the basis of ingredient, it is fragmented into carbohydrates, fat, protein, minerals, vitamins, and others. By distribution channel, it is categorized into hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others. By source, it is classified into regular, organic, milk with HMO, goat milk, plant-based formula, and others.
The major players analyzed for the U.S. Baby Infant Formula Market are Abott Laboratories, Alra Foods Amba, Aussie Bub, Bobbie, Campbell Soups Company, Dana Dairy Group Ltd., Danone SA, D-Signstore, Else Nutrition Holdings Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC, Nestle S.A, Reckitt Benckiser Group Plc, and The Hain Celestial Group, Inc.
Key benefits for the stakeholder
- The report provides an in-depth analysis of the current trends, drivers, and dynamics of the U.S. baby infant formula market to elucidate the prevailing opportunities and potential investment pockets.
- It offers qualitative trends and quantitative analysis for the period of 2020-2030 to assist stakeholders to understand the market scenario.
- In-depth analysis of the key segments demonstrates the trending types across the U.S.
- Competitive intelligence of the industry highlights the business practices followed by key players across the U.S. and the prevailing market opportunities.
- The key players are profiled along with their strategies and developments to understand the competitive outlook of the industry.
Key Market Segments
By Product Type
- Infant milk
- Follow-on-milk
- Specialty baby milk
- Growing-up milk
By Ingredient
- Carbohydrate
- Fat
- Protein
- Minerals
- Vitamins
- others
By Distribution Channel
- Hypermarkets
- Supermarkets
- Pharmacy/medical stores
- Specialty stores
- Hard discounter stores
- others
By Source
- Regular
- Organic
- Milk with HMO
- Goat milk
- Plant-based formula
- Others
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: U.S. BABY INFANT FORMULA MARKET, BY PRODUCT TYPE
CHAPTER 5: U.S. BABY INFANT FORMULA MARKET, BY INGRIDIENT
CHAPTER 6: U.S. BABY INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 7: U.S. BABY INFANT FORMULA MARKET, BY SOURCE
CHAPTER 8: COMPETITION LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
U.S. Baby Infant Formula Market is Expected to Reach $6,784.7 Million by 2030.Baby infant formula is a uniquely prepared nutritious substitute for breast milk. It is specially designed to provide necessary nutrients to infants to have a healthy development. It is available in the form of powder, liquid, or ready-to-feed form. Moreover, it is incorporated with a rich combination of proteins, carbohydrates, fats, vitamins, and minerals. This formula is applicable as a complete or partial substitute for breast milk.
The U.S. Baby Infant Formula market is segmented on the basis of product type, ingredient distribution channel, and source. By product type, the market is divided into infant milk, follow-on milk, specialty baby milk, and others. By ingredient, the market is classified into carbohydrates, fat, protein, minerals, vitamins, and others. By distribution channel, the market is fragmented into hypermarkets, supermarkets, pharmacy/ medical stores, specialty stores, hard discounters’ stores, and others. By source, the market is segregated into regular, organic, milk with HMO, goat milk, plant-based formula, and others.
The food & beverage sector is one of the key sectors meeting the needs of the growing population. Moreover, the rise in the female working population has eventually resulted in a surge in demand for baby infant formula. According to the U.S. Bureau of Statistics, the working women population has increased from 57.1% in 2018 to 57.5% in 2020. Most mothers rebound to their professional schedule immediately after the birth of the child. Consequently, the imbalance of the breastfeeding schedule results in the adoption of convenient alternatives such as baby infant formula. Owing to the rise in the population of working women, the demand for baby infant formula has accelerated. This is attributed to easy preparedness along with the easy storage capacity of baby infant formula. It serves as a convenient alternative for busy parents as the infant formula lasts longer than breastmilk. In addition, the rise in unhealthy lifestyles along with medical conditions results in insufficient milk production. In some situations, infants are prescribed for the consumption of formula. These factors have accelerated the demand for baby infant formula in the U.S.
The regulatory bodies have been alerting the benefits of breastfeeding. This has resulted in the implementation of initiatives to promote and support breastfeeding. It is considered the absolute way of providing healthy growth to an infant. Many promotional activities are done by policymakers and health activists. The consideration of breast milk as the best suitable diet for infants hampers the market of baby infant formula in the U.S. The organizations that support breastfeeding uplift parents to cook baby foods for babies after the age of six months. Furthermore, many sectors provide extra maternity leave to support breastfeeding. Other workplace supports such as breastfeeding breaks and the presence of private spaces for nursing mothers have encouraged breastfeeding activity among parents.
Prebiotics and probiotics are utilized to maintain the healthy being of the guts. They promote the growth of beneficial bacteria. Moreover, infant formula providers have included the use of prebiotics and probiotics in infant formula, after extensive R&D activities. In addition, major key players are supporting the use of these microorganisms owing to their nourishing and functional properties. Prebiotics and probiotics are categorized as GRAS (generally regarded as safe) by the FDA and are promoted as an ingredient in commercial infant formulas. For instance, many key players have introduced Hipp Dutch Stage 1 (0-6 Months) Organic Combiotic Infant Milk Formula, Kendamil Stage 1 (0-6 Months) Organic Baby Formula: (prebiotics), Earth’s Best Organic Toddler (prebiotics), Earth’s Best Organic Dairy (prebiotics) by the Hain Celestial, and Similac Probiotic Tri-Blend Supplement Powder. These factors are expected to provide growth opportunities for the industry leaders to boost their product sales in the U.S. baby infant formula market in the upcoming years.
The major players analyzed for the U.S. Baby Infant Formula Market are Abbott Laboratories, Arla Foods Amba, Aussie Bub, Bobbie, Campbell Soups Company, Dana Dairy Group Ltd., Danone SA, D-Signstore, Else Nutrition Holdings Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC, Nestle S.A, Reckitt Benckiser Group Plc, and The Hain Celestial Group, Inc.
Key Findings of the Study
- By product type, the infant milk segment was the highest revenue contributor to the market, with $2,204 million in 2020, and is estimated to reach $3,894.5 million by 2030, with a CAGR of 8.8%.
- By ingredient, the carbohydrate segment was the highest revenue contributor to the market, with $2,195.0 million in 2020, and is estimated to reach $3,789.3 million by 2030, with a CAGR of 8.4%.
- Depending on the distribution channel, the Hypermarket segment was the highest revenue contributor to the market, with $1,241 million in 2020, and is estimated to reach $2,078.1 million by 2030, with a CAGR of 7.9%.
- By source, regular was the highest revenue contributor, accounting for $1,412.5 million in 2020, and is estimated to reach $2,293.3 million by 2030, with a CAGR of 7.5%.
Companies Mentioned
- Abbott Laboratories
- Arla Foods
- Bobbie
- Campbell Soups Company
- Dana Dairy Group, Ltd.
- Danone S.A.
- D-Signstore
- Else Nutrition Holdings, Inc.
- Hipp GmbH & Co.
- Vertrieb KG
- Holle Baby Food AG
- Kabrita USA, Nature’s One, LLC.
- Nestle S.A.
- Reckitt Benckiser Group Plc.
- The Hain Celestial Group, Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Related Reports
From
From
United States Baby Infant Formula Market Report and Forecast 2023-2028
- Report
- 154 Pages
- United States
From
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
